FDA approves Spectrum's Reb X sweetener as 'generally recognized safe'
-
Last Update: 2021-02-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
"
Generally Recognized Safety
"
(
GRAS
) declared
FDA
in May, the world's largest producer and seller of stevia sugar
PureCircle
is pleased to announce that the U.S. Food and Drug Administration (
FDA
) has approved
PureCircle
's
Reb M
as a generic sweetener for U.S. food and beverages.High Purity
Reb M (
also known as
Reb X
tastes closer to table sugar than previous stevia sugar ingredients, reducing calories in food and beverage products to a greater extent, especially those with higher sweet taste levels.The discovery and
Reb M's development was the result of a previously announced joint development and five-year supply agreement with Coca-Cola. Meanwhile
2
are seeking the global IP coverage of the ingredient.high purity with pure, sugar-like sweetness
Reb M
appeals to consumers who seek natural, calorie-free, sweet food and beverage formulations. Its commercialization will play an important role in expanding
PureCircle
's breakthrough stevia sugar
3.0
innovation to optimize the taste of stevia as a sweetener food and beverage.PureCircle
's
Reb M
's certification of
"
Generally Recognized Safetyadds weight to the company's leadership in bringing stevia sugar innovation to market.
Jason He
cker, vice president of global marketing and innovation at pureCircle
, commented:
supports the commercialization of
Reb M
by continuing to invest in supply chain capital
production and leaf development. We
excited about
opportunities in the Stevia Sugar
3.0
range of features demonstrated by reb M.
”
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.